Email Subscription

Enter your email address:

Delivered by FeedBurner

Tuesday, January 11, 2022

Molnupiravir gains outweigh risks: Experts counter ICMR

Leading Covid-19 task force members and health experts treating coronavirus patients across the country said on Monday that the Covid antiviral drug molnupiravir is reducing hospitalisation by 30-50 %, as well as the severity of the disease.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3ncSMdm

No comments:

Post a Comment

Please do not enter any spam link in the comment box